Exports fuel Analytik Jena's sales recovery
This article was originally published in Clinica
Executive Summary
Analytik Jena, which manufactures analytical instrumentation technology for life sciences, biotechnology, environmental and energy technology, increased its sales by 10% during the first quarter of 2002-03. The Jena, Germany-based company said that domestic sales had fallen by 20.7% to E14.2m for the first quarter. Sales in the company's analytical solutions and bioanalytical solutions business units fell slightly to E6.3m, compared with E6.7m during the same period for 2001/-02. In contrast, exports more than tripled to E8.16, compared with E2.5m for the same period last year. It now makes more than a third of its sales outside Germany.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.